Sarcoidosis

Ann Allergy Asthma Immunol. 2018 Dec;121(6):662-667. doi: 10.1016/j.anai.2018.08.010. Epub 2018 Aug 28.

Authors

Vivian Wang¹, Fonda Jiang¹, Anita Kallepalli¹, Tyler Basen¹, Joseph Yusin¹, Guha Krishnaswamy²

Affiliations

¹ Department of Allergy and Immunology, VA Greater Los Angeles Healthcare System, Los Angeles, California.
² Wake Forest School of Medicine and the Wake Baptist Hospital, Winston Salem, North Carolina; W.G. (Bill) Hefner VA Medical Center and Affiliated Clinics, Salisbury, North Carolina. Electronic address: gkrishna@wakehealth.edu.

PMID: 30170027
DOI: 10.1016/j.anai.2018.08.010

No abstract available

MeSH terms

Anti-Inflammatory Agents / therapeutic use*
Glucocorticoids / therapeutic use*
HLA-DQ beta-Chains / genetics
HLA-DRB1 Chains / genetics
Humans
Prednisone / therapeutic use
Sarcoidosis* / diagnosis
Sarcoidosis* / drug therapy
Sarcoidosis* / genetics
Sarcoidosis* / immunology
Th1 Cells / immunology

Substances

Anti-Inflammatory Agents
Glucocorticoids
HLA-DQ beta-Chains
HLA-DRB1 Chains
Prednisone